Guy G. Poirier

Guy G. Poirier

Auto-generated profile, based on publicly available information

Guy G. Poirier

Department of Molecular Biology, Medical Biochemistry and Pathology, Faculty of Medicine Université Laval Québec City Quebec Canada

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2018 in Science
Verified
Journal Article
Closed access
PDF file
TKTae-In Kam
Tae-In Kam
Xiaobo MaoXiaobo Mao
Xiaobo Mao
HPHyejin Park
Hyejin Park
SCShih-Ching Chou
Shih-Ching Chou
Senthilkumar S. KaruppagounderSenthilkumar S. Karuppagounder
Senthilkumar S. Karuppagounder
VDValina L. Dawson
Valina L. Dawson
PAR promotes α-synuclein toxicity: How pathologic α-synuclein (α-syn) leads to neurodegeneration in Parkinson's disease (PD) remains poorly understood. Kam et al. studied the α-syn preformed fibril (α-syn PFF) model of sporadic PD (see the Perspective by Brundin and Wyse). They found that pathologic α-syn–activated poly(adenosine 5′-diphosphate–ribose) (PAR) polymerase–1 (PARP-1) and inhibition of PARP or knockout of PARP-1 protected mice from pathology. The generation of PAR by α-syn PFF–induced PARP-1 activation converted α-syn PFF to a strain that was 25-fold more toxic, termed PAR–α-syn PFF. An increase of PAR in the cerebrospinal fluid and evidence of PARP activation in the substantia nigra of PD patients indicates that PARP activation contributes to the pathogenesis of PD through parthanatos and conversion of α-syn to a more toxic strain. Science , this issue p. eaat8407 ; see also p. 521

4 July 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
MCMarie-Christine Caron
Marie-Christine Caron
ASAjit K. Sharma
Ajit K. Sharma
JOJulia O’sUllivan
Julia O’sUllivan
LMLogan R. Myler
Logan R. Myler
MFMaria Tedim Ferreira
Maria Tedim Ferreira
JMJean-Yves Masson
Jean-Yves Masson
PARP-1 is rapidly recruited and activated by DNA double-strand breaks (DSBs). Upon activation, PARP-1 synthesizes a structurally complex polymer composed of ADP-ribose units that facilitates local chromatin relaxation and the recruitment of DNA repair factors. Here, we identify a function for PARP-1 in DNA DSB resection. Remarkably, inhibition of PARP-1 leads to hyperresected DNA DSBs. We show that loss of PARP-1 and hyperresection are associated with loss of Ku, 53BP1 and RIF1 resection inhibitors from the break site. DNA curtains analysis show that EXO1-mediated resection is blocked by PARP-1. Furthermore, PARP-1 abrogation leads to increased DNA resection tracks and an increase of homologous recombination in cellulo. Our results, therefore, place PARP-1 activation as a critical early event for DNA DSB repair activation and regulation of resection. Hence, our work has direct implications for the clinical use and effectiveness of PARP inhibition, which is prescribed for the treatment of various malignancies.

12 March 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
JOJulia O’sUllivan
Julia O’sUllivan
MFMaria Tedim Ferreira
Maria Tedim Ferreira
JGJean-Philippe Gagné
Jean-Philippe Gagné
ASAjit K. Sharma
Ajit K. Sharma
MHMichael J. Hendzel
Michael J. Hendzel
GPGuy G. Poirier
Guy G. Poirier
Protein ADP-ribosylation is essential for the regulation of several cellular pathways, enabling dynamic responses to diverse pathophysiological conditions. It is modulated through a dynamic interplay between ADP-ribose readers, writers and erasers. While ADP-ribose synthesis has been studied and reviewed extensively, ADP-ribose processing by erasing enzymes has received comparably less attention. However, major progress in the mass spectrometric identification of ADP-ribosylated residues and the biochemical characterization of ADP-ribose erasers has substantially expanded our knowledge of ADP-ribosylation dynamics. Herein, we describe recent insights into the biology of ADP-ribose erasers and discuss the intricately orchestrated cellular processes to switch off ADP-ribose-dependent mechanisms.

17 February 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
IMImene Melki
Imene Melki
IAIsabelle Allaeys
Isabelle Allaeys
NTNicolas Tessandier
Nicolas Tessandier
TLTania Lévesque
Tania Lévesque
NCNathalie Cloutier
Nathalie Cloutier
EBEric Boilard
Eric Boilard
Platelets are a source of extracellular DNA and mitochondrial antigens in systemic lupus erythematosus.

15 April 2003 in Biochemical Journal
Verified
Journal Article
Open access
PDF file
JGJean-Philippe Gagne
Jean-Philippe Gagne
JHJoanna M. Hunter
Joanna M. Hunter
BLBenoît Labrecque
Benoît Labrecque
Benoit ChabotBenoit Chabot
Benoit Chabot
GPGuy G. Poirier
Guy G. Poirier
A new class of poly(ADP-ribose) (pADPr)-binding proteins, heterogeneous nuclear ribonucleoproteins (hnRNPs), has been identified by a proteomic approach using matrix-assisted laser-desorption–ionization time-of-flight ('MALDI-TOF') MS. Liquid-phase isoelectric focusing with a Rotofor® cell (Bio-Rad) allowed pre-fractionation of proteins extracted from HeLa cells. Rotofor® protein fractions were further separated by SDS/PAGE and then transferred to a PVDF membrane. pADPr-binding proteins were analysed by autoradiography of the protein blot after incubation with 32P-labelled automodified pADPr polymerase-1 (PARP-1). Peptide mass fingerprinting of selected bands identified the most abundant pADPr-binding proteins as hnRNPs, a family of proteins that bind pre-mRNA into functional complexes involved in mRNA maturation and transport to the cytoplasm. Sequence homology database searching against a previously reported pADPr-binding sequence motif revealed that the hnRNPs contain a putative pADPr-binding sequence pattern [Pleschke, Kleczkowska, Strohm and Althaus (2000) J. Biol. Chem. 275, 40974–40980]. pADPr-binding assays performed with synthetic peptides by the dot-blot technique and with nitrocellulose-transferred recombinant hnRNPs confirmed the pADPr-binding protein identification and the specificity of the interaction. These results could establish a link between increased levels of pADPr in DNA damaged cells and the modified protein expression pattern resulting from altered mRNA trafficking.

2 August 2018 in eLife
Verified
Journal Article
Open access
GBGiulia Bertolin
Giulia Bertolin
anne-laure bulteauanne-laure bulteau
anne-laure bulteau
MAMarie-Clotilde Alves-Guerra
Marie-Clotilde Alves-Guerra
ABAgnes Burel
Agnes Burel
MLMarie-Thérèse Lavault
Marie-Thérèse Lavault
Marc TramierMarc Tramier
Marc Tramier
Many epithelial cancers show cell cycle dysfunction tightly correlated with the overexpression of the serine/threonine kinase Aurora A (AURKA). Its role in mitotic progression has been extensively characterised, and evidence for new AURKA functions emerges. Here, we reveal that AURKA is located and imported in mitochondria in several human cancer cell lines. Mitochondrial AURKA impacts on two organelle functions: mitochondrial dynamics and energy production. When AURKA is expressed at endogenous levels during interphase, it induces mitochondrial fragmentation independently from RALA. Conversely, AURKA enhances mitochondrial fusion and ATP production when it is over-expressed. We demonstrate that AURKA directly regulates mitochondrial functions and that AURKA over-expression promotes metabolic reprogramming by increasing mitochondrial interconnectivity. Our work paves the way to anti-cancer therapeutics based on the simultaneous targeting of mitochondrial functions and AURKA inhibition.